Prednisolon sodium phosphate (equivalent to prednisolon phosphate) 1 mg/ml

Oral solution

1. Allergic States
Control of severe or incapacitating allergic conditions intractable to adequate trials of
conventional treatment in adult and pediatric populations with: seasonal or perennial allergic
rhinitis; asthma; contact dermatitis; atopic dermatitis; serum sickness; drug hypersensitivity
reactions.
2. Dermatologic Diseases
Pemphigus; bullous dermatitis herpetiformis; severe erythema multiforme (Stevens-Johnson
syndrome); exfoliative erythroderma; mycosis fungoides.
3. Edematous States
To induce diuresis or remission of proteinuria in nephrotic syndrome in adults with lupus
erythematosus and in adults and pediatric populations, with idiopathic nephrotic syndrome,
without uremia.
4. Endocrine Disorders
Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first
choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable;
in infancy mineralocorticoid supplementation is of particular importance); congenital adrenal
hyperplasia; hypercalcemia associated with cancer; nonsuppurative thyroiditis.
5. Gastrointestinal Diseases
To tide the patient over a critical period of the disease in: ulcerative colitis; regional enteritis.
6. Hematologic Disorders
Idiopathic thrombocytopenic purpura in adults; selected cases of secondary thrombocytopenia;
acquired (autoimmune) hemolytic anemia; pure red cell aplasia; Diamond-Blackfan anemia.
7. Neoplastic Diseases
For the treatment of acute leukemia and aggressive lymphomas in adults and children.
8. Nervous System
Acute exacerbations of multiple sclerosis.
9. Ophthalmic Diseases
Uveitis and ocular inflammatory conditions unresponsive to topical corticosteroids; temporal arteritis; sympathetic ophthalmia.
10. Respiratory Diseases
Symptomatic sarcoidosis; idiopathic eosinophilic pneumonias; fulminating or disseminated
pulmonary tuberculosis when used concurrently with appropriate antituberculous chemotherapy;
asthma (as distinct from allergic asthma listed above under “Allergic States”), hypersensitivity
pneumonitis, idiopathic pulmonary fibrosis, acute exacerbations of chronic obstructive
pulmonary disease (COPD), and Pneumocystis carinii pneumonia (PCP) associated with

hypoxemia occurring in an HIV (+) individual who is also under treatment with appropriate anti-
PCP antibiotics. Studies support the efficacy of systemic corticosteroids for the treatment of

these conditions: allergic bronchopulmonary aspergillosis, idiopathic bronchiolitis obliterans
with organizing pneumonia.
11. Rheumatic Disorders
As adjunctive therapy for short term administration (to tide the patient over an acute episode or
exacerbation) in: psoriatic arthritis; rheumatoid arthritis, including juvenile rheumatoid arthritis
(selected cases may require low dose maintenance therapy); ankylosing spondylitis; acute and
subacute bursitis; acute nonspecific tenosynovitis; acute gouty arthritis; epicondylitis. For the
treatment of systemic lupus erythematosus, dermatomyositis (polymyositis), polymyalgia
rheumatica, Sjogren’s syndrome, relapsing polychondritis, and certain cases of vasculitis.
12. Miscellaneous
Tuberculous meningitis with subarachnoid block or impending block, tuberculosis with enlarged
mediastinal lymph nodes causing respiratory difficulty, and tuberculosis with pleural or
pericardial effusion (appropriate antituberculous chemotherapy must be used concurrently when
treating any tuberculosis complications); Trichinosis with neurologic or myocardial involvement;
acute or chronic solid organ rejection (with or without other agents).